Carey Hendrickson - Dec 12, 2022 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)

Role: Chief Financial Officer
Signature: /s/ Carey Hendrickson
Stock symbol: USPH
Transactions as of: Dec 12, 2022
Transactions value $: -$48,318
Form type: 4
Date filed: 12/13/2022, 11:29 AM
Previous filing: Sep 13, 2022
Next filing: Feb 23, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	USPH	Common Stock	Sale	-$48.3K	-550	-4.52%	$87.85	11.6K	Dec 12, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price $87.85. The shares were sold in multiple transactions at prices ranging from $87.76 to $87.92 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2	Included are 7,944 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in quarterly installments as follows: 698 shares on each of January 1, April 1, July 1, October 1, 2023 and January 1, April 1, and July 1, 2024; 706 shares on October 1, 2024; 468 shares on each of January 1, April 1, July 1 and October 1, 2025; and 480 shares on January 1, 2026.

Content

The price reported is a weighted average price $87.85. The shares were sold in multiple transactions at prices ranging from $87.76 to $87.92 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Included are 7,944 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in quarterly installments as follows: 698 shares on each of January 1, April 1, July 1, October 1, 2023 and January 1, April 1, and July 1, 2024; 706 shares on October 1, 2024; 468 shares on each of January 1, April 1, July 1 and October 1, 2025; and 480 shares on January 1, 2026.